Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7...
Transcript of Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7...
![Page 1: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/1.jpg)
1
Prevent development of
diabetes in high risk
subjects
Henk Bilo
Cardiology and Vascular Medicine 2011 Congress
De Doelen, Rotterdam, 23 may, 2011
![Page 2: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/2.jpg)
2
Prevent development of
type 2 diabetes in high
risk subjects
Henk Bilo
Cardiology and Vascular Medicine 2011 Congress
De Doelen, Rotterdam, 23 may, 2011
![Page 3: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/3.jpg)
T2DM: Heterogenic disease
• Predominantly insulin resistance with relative
insulin deficiency
• predominantly secretory defect with insulin
resistance
• Predominantly beta cell failure without
complete loss of insulin secretory capacity
• Gestational diabetes
![Page 4: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/4.jpg)
Complications in T2DM
• Microvascular complications
– nephropathy
– retinopathy
– neuropathy
• macrovascular complications
– CHD
– CVD
– Peripheral vascular disease
Mortality
Macro/micro:
70 : 1
Morbidity
Macro/micro:
4 : 1
![Page 5: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/5.jpg)
2002
![Page 6: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/6.jpg)
2006
![Page 7: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/7.jpg)
7
Prevalence DM 2010-2030
2010 2030
World population (billions) 7.0 8.4
Adults (20-79 jaar) 4.3 5.6
Diabetes prevalence (%) 6.6 7.8
Total (millions) 285 438
IGT prevalence (%) 7.9 8.4
Total (millions) 344 472
Source: IDF
![Page 8: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/8.jpg)
8
![Page 9: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/9.jpg)
9
![Page 10: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/10.jpg)
10
![Page 11: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/11.jpg)
11
![Page 12: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/12.jpg)
12
![Page 13: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/13.jpg)
13
![Page 14: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/14.jpg)
BMI > 25 kg/m² in The Netherlands
![Page 15: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/15.jpg)
BMI ≥ 30 kg/m² in The Netherlands
![Page 16: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/16.jpg)
<40 40-45 45-50 50-55 55-60 60-65 65-70 70-75 75-80 80-85 >85
Age (years)
22,5
25,0
27,5
30,0
32,5
35,0
37,5
40,0
42,5
45,0
BM
I (k
g/m
2)
T2DM incidence and BMI
Diabeteszorgbeter cohort 2006
![Page 17: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/17.jpg)
17
![Page 18: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/18.jpg)
18
![Page 19: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/19.jpg)
19
Disparities in healthcare spending
There is a large disparity in healthcare spending on diabetes
between regions and countries. More than 80% of the
estimated global expenditures on diabetes are made in the
world’s economically richest countries, not in the low- and
middle-income countries where over 70% of people with
diabetes live.
One country, the United States of America, is projected to spend
USD198 billion or 52.7% of global expenditure in 2010, while
India, the country with the largest population of people living
with diabetes, is expected to spend an estimated USD2.8
billion, or less than 1% of the global total. An estimated
average of USD7,383 per person with diabetes is expected to
be spent on diabetes-related care in the USA but less than
USD10 per person will be spent in Burundi, Côte d’Ivoire and
Myanmar in 2010.
![Page 20: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/20.jpg)
20
Net losses in national income
Country US dollars (billion)
USA 2007 58.0
DM and CV disease 2005-2015
China 557.7
Russia 303.2
India 236.6
Brazil 49.2
Tanzania 2.5
![Page 21: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/21.jpg)
21
Risk factors and associated disorders
Diabetic Medicine 2007, IDF consensus
![Page 22: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/22.jpg)
22
DPP, NEJM 2002
![Page 23: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/23.jpg)
23
DPP, NEJM 2002
![Page 24: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/24.jpg)
24
DPS, Lancet 2006
![Page 25: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/25.jpg)
25
DPS, Lancet 2006
![Page 26: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/26.jpg)
26
Da Qing, Diabetes Care 1997
![Page 27: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/27.jpg)
27
Da Qing, Lancet 2009
![Page 28: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/28.jpg)
28
Da Qing, Lancet 2009
![Page 29: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/29.jpg)
29
IDPP-1, Diabetologia 2006
![Page 30: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/30.jpg)
30
IDPP-2, Diabetologia 2009
Pioglitazone vs placebo
![Page 31: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/31.jpg)
31
Major diabetes prevention studies
Diabetic Medicine 2007, IDF consensus
![Page 32: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/32.jpg)
32
Screening tools
Might be different from
country to country, and
from population to
population
Prevention strategies- General
- Indicated
![Page 33: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/33.jpg)
33
![Page 34: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/34.jpg)
34
![Page 35: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/35.jpg)
35
Ethnic groups and
environment
![Page 36: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/36.jpg)
36
Pharmacological
interventions
at present:
Metformin
TZD’s
Acarbose
ACE-inhibitors?
AIIA’s?
(near) future:
Weight loss enhancers
Gut hormones (GLP-1
analogues)
![Page 37: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/37.jpg)
37
Non-pharmacological
interventions
Prevent overweight
Keep active from young
age
Eat healthy
Combat overweight
Start exercising
(Stop fast food, avoid
softdrinks)
Maintain the gain
![Page 38: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/38.jpg)
NICE public health guidance 35
![Page 39: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/39.jpg)
39
![Page 40: Prevent development of diabetes in high risk subjects · DM and CV disease 2005-2015 China 557.7 Russia 303.2 India 236.6 Brazil 49.2 Tanzania 2.5. 21 Risk factors and associated](https://reader036.fdocuments.us/reader036/viewer/2022080718/5f78af3063e6b70868614e9a/html5/thumbnails/40.jpg)
40